Subcutaneous epcoritamab in patients with relapsed/refractory chronic lymphocytic leukemia: Preliminary results from the EPCORE CLL-1 trial Meeting Abstract


Authors: Kater, A. P.; Christensen, J. H.; Bentzen, H. H.; Niemann, C. U.; Hutchings, M.; Chen, J.; Rios, M.; Palenski, T.; Li, T.; Mato, A. R.
Abstract Title: Subcutaneous epcoritamab in patients with relapsed/refractory chronic lymphocytic leukemia: Preliminary results from the EPCORE CLL-1 trial
Meeting Title: 63rd Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 138
Issue: Suppl. 1
Meeting Dates: 2021 Dec 11-14
Meeting Location: Atlanta, GA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2021-11-23
Language: English
ACCESSION: WOS:000736413902140
DOI: 10.1182/blood-2021-146563
PROVIDER: wos
Notes: Meeting Abstract: 2627 -- Hybrid meeting, also took place online -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Anthony R Mato
    235 Mato